The headline revision is straightforward: CMHC expects home prices to decline through 2026 and then grow only modestly afterward, with very slow population growth and limited income gains keeping any increases restrained across the country. In its summer update, CMHC frames 2026 as a year of weak demand rather than a second-half turnaround, with baseline real GDP growth of just 0.7% weighing on confidence, mobility, and buyers' capacity to stretch.
The reasons CMHC gives are worth separating out, because they explain why cheaper homes have not restarted the market. Activity has run weaker than expected this year on a combination of slower population growth, ongoing economic uncertainty, high mortgage rates, and slow income growth. Improved affordability, CMHC notes, has not been enough on its own to bring many buyers back. That is the crux of the delayed-recovery case: lower prices are not a switch that flips demand back on when three or four other constraints are still pressing.
CMHC also named its biggest downside risks, and both sit outside the housing market. It flagged renewed U.S.–Canada trade tension — including a newly announced 50% U.S. tariff move that the Prime Minister's Office addressed days earlier — alongside the U.S.–Iran conflict, which CMHC expects to push inflation up temporarily in 2026. Both channels can suppress hiring, investment, and demand for homes.
CMHC's revision is not an outlier, either. It lands amid a broader wave of downgrades, including TD Economics' own reversal from the growth it had projected in December.
The national baseline table puts numbers on the slow-grind picture:
Prices recover only gradually while starts keep falling — a profile consistent with a weak, extended adjustment, not a snapback.